F
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform
About Feldan Therapeutics
Feldan Therapeutics is a biopharmaceutical company focused on developing breakthrough treatments that work within cells. The company operates in the healthcare and biotechnology market, targeting medical professionals and institutions that require advanced therapeutic solutions. Feldan's core product is the Feldan Shuttle, a unique peptide-based technology that allows for the intracellular delivery of therapeutics, reaching targets that existing drugs cannot. This innovative approach aims to improve the quality of life by addressing unmet medical needs. Feldan generates revenue through the development and commercialization of its proprietary technologies and therapeutic solutions, partnering with other biotech firms and healthcare providers to bring its products to market.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2025 | $0 | — | Zynext Ventures | ↗ |
| LATE VCOther financing | Feb 2025 | $0 | — | Invest Quebec · Fonds de solidarité FTQ · Amgen Ventures · Genesys Capital | ↗ |
Growth signals
Latest recorded traffic for Feldan Therapeutics is 2.3K monthly website visits, up 164.4% over the last three months. Feldan Therapeutics's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Feldan Therapeutics in the Quebec City ecosystem
The Feldan Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Anges Quebec- FSFIER Succes
Cystic Fibrosis Foundation
Series A9 investors entered at this stage
AQC Capital
Stonebridge Ventures
Invest Quebec
GC LabCell- FSFSITII
Amgen Ventures- GPGC Pharma
Fonds de solidarité FTQ
Genesys Capital
Series B and later2 investors entered at this stage
Linear Capital
Zynext Ventures
Other known investors1 additional known investor
Laval University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Feldan Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Feldan Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









